At the other end of the FTSE 100, Mediclinic International weighed. The private healthcare chain slipped by 17½p to 538p after confirming that talks with Spire, its mid-cap peer, had ended without an agreement. “Accordingly, Mediclinic does not intend to make an offer for Spire,” it told investors.
Disclaimer: Please note all prices are for information only, they should not be relied upon for accuracy or trading. All prices quotes are based on CFD prices and are similar though not always identical to real exchange prices. STOCKTRKR or anybody connected with STOCKTRKR will not accept any liability for loss or damage arising from use of any information/commentary/charts or articles which is provided 'as is' for educational purposes only, nothing contained on this website should be considered as investment advice - please seek proper investment advice from registered financial broker or institution if you wish to trade on global markets and ensure you are familiar with the risks.
